Neutralization of biotin interference: preliminary evaluation of the VeraTest Biotin™, VeraPrep Biotin™ and BioT-$ Filter^{®} $
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:58 |
|---|---|
| Enthalten in: |
Clinical chemistry and laboratory medicine - 58(2020), 8 vom: 24. Feb., Seite e130-e133 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Favresse, Julien [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: |
|---|
| Anmerkungen: |
©2020 Walter de Gruyter GmbH, Berlin/Boston |
|---|
| doi: |
10.1515/cclm-2019-1121 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
GRUY007203357 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | GRUY007203357 | ||
| 003 | DE-627 | ||
| 005 | 20231205155826.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230811s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1515/cclm-2019-1121 |2 doi | |
| 035 | |a (DE-627)GRUY007203357 | ||
| 035 | |a (DE-B1597)cclm-2019-1121-e | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 540 |a 610 |q VZ |
| 082 | 0 | 4 | |a 540 |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 44.46 |2 bkl | ||
| 100 | 1 | |a Favresse, Julien |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neutralization of biotin interference: preliminary evaluation of the VeraTest Biotin™, VeraPrep Biotin™ and BioT-$ Filter^{®} $ |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a ©2020 Walter de Gruyter GmbH, Berlin/Boston | ||
| 700 | 1 | |a Bayart, Jean-Louis |4 aut | |
| 700 | 1 | |a Stoefs, Anke |4 aut | |
| 700 | 1 | |a Gheldof, Damien |4 aut | |
| 700 | 1 | |a Douxfils, Jonathan |0 (orcid)0000-0002-7644-5298 |4 aut | |
| 700 | 1 | |a Dogné, Jean-Michel |4 aut | |
| 700 | 1 | |a Gruson, Damien |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d De Gruyter, 1998 |g 58(2020), 8 vom: 24. Feb., Seite e130-e133 |h Online-Ressource |w (DE-627)GRUY000051497 |w (DE-600)1492732-9 |w (DE-576)088704882 |x 1437-4331 |7 nnns |
| 773 | 1 | 8 | |g volume:58 |g year:2020 |g number:8 |g day:24 |g month:02 |g pages:e130-e133 |
| 856 | 4 | 0 | |u https://dx.doi.org/10.1515/cclm-2019-1121 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_GRUY | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 936 | b | k | |a 44.46 |j Klinische Pathologie |q VZ |
| 951 | |a AR | ||
| 952 | |d 58 |j 2020 |e 8 |b 24 |c 02 |h e130-e133 | ||